NovelDx in the News
Gov. Wes Moore and Maryland Department of Commerce Award $633K Grant to Novel Microdevices
Baltimore, Maryland – June 19, 2025 – Novel Microdevices, Inc. has been awarded $633,757 through the Build Our Future Grant Pilot Program by the Maryland Department of Commerce. The grant will support the establishment of a GMP-compliant pilot manufacturing facility at the company’s Baltimore City headquarters for production of innovative microfluidic cartridges used in its sample-to-answer diagnostic platform. This facility will enable scaling to fully automated custom manufacturing lines, accelerating delivery of 15-minute PCR tests for infectious diseases like Flu, RSV, COVID-19, and STIs...
Novel Microdevices 2024 Mayor’s Awards Profile
Novel Microdevices Secures $2.7 Million in Follow-On Funding from NIH RADx® Tech Program After Achieving Key Milestones
Baltimore, Maryland – November 8, 2024 – Novel Microdevices, Inc., a leader in medical diagnostic innovation, announces the award of an additional $2.68 million in follow-on funding from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program. The funding follows the successful completion of critical performance milestones for its high-performance, point-of-care RT-PCR platform, which rapidly detects RSV, Influenza A, Influenza B, and COVID-19 in just 15 minutes.
Baltimore’s Novel Microdevices, Inc. Awarded $1.4M NIH RADx® Funding for Point-of-Care RT-PCR Test
Novel Microdevices, Inc. Awarded ~$1.4M from NIH RADx® Tech to Develop a Next-generation, High Performance, Point-of-Care RT-PCR Test
Novel Microdevices secures $1.4M award from the NIH
The East Baltimore-based company seeks to revolutionize diagnostics through swift and accurate point-of-care testing.
The Baltimore Sun’s 25 Women to Watch 2021: Best in advocacy, business and health (Baltimore Sun staff)
The Baltimore Sun’s 25 Women to Watch 2021: Best in advocacy, business and health (Baltimore Sun staff) Andrea Pais is the co-founder and CEO of Novel Microdevices, a developer of diagnostic testing systems. (PHOTO by Lloyd Fox/Baltimore Sun) Growing up in South India, Andrea Pais saw firsthand the need for portable, rapid testing for all sorts of illnesses — especially in remote areas of the country, which she said sometimes are days away from the nearest hospital. It drove the 37-year-old Baltimore-based entrepreneur to co-found Novel Microdevices in 2015 and begin developing a testing...
Carb-X announces up to $13.8m funding for STIs diagnostic
Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections
CARB-X Funding Announcement
April 6th, 2021, 7:00 AM ET Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections (Baltimore, Maryland) - Novel Microdevices, Inc.,(Novel) a developer of an innovative molecular diagnostics platform, announced today that CARB-X has awarded it up to $13.8 million in non-dilutive funding to develop its next-generation rapid molecular test for the diagnosis of sexually transmitted bacterial infections,...